Henan Lingrui Pharmaceutial Co., Ltd.SSE: 600285

2025 Semi-annual Report

Aug 20, 2025 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 20, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-24

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Henan Lingrui Pharmaceutial Co., Ltd. on 6ix

Earlier from Henan Lingrui Pharmaceutial

Announcement on Convening the 2025 Semi-annual Performance BriefingAug 16, 2025
Announcement on Implementation of Dividend Distribution for 2024Jun 13, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 21, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Henan JurisdictionMay 17, 2025
Announcement on Additional Subscription of Private Fund SharesApr 26, 2025

Later from Henan Lingrui Pharmaceutial

Announcement on Shareholding Reduction Plan for DirectorsSep 16, 2025
Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Some Corporate Governance SystemsOct 30, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 11, 2025
Announcement on Resignation of Senior Management MemberDec 31, 2025
Announcement on "Corporate Value and Return Enhancement" Action PlanJan 1

All Henan Lingrui Pharmaceutial news releases

Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.

Follow Henan Lingrui Pharmaceutial